Y.-Q. Wang, Y. Zhang, H. Dong, J. Zhang, J. Zhao
FULL PAPER
1
ate, 5:1). H NMR (400 MHz, CDCl3): δ = 7.59 (d, J = 10.4 Hz, 1 129.40, 129.35, 129.1, 128.8, 113.4, 113.1, 104.7, 67.9, 67.0, 56.6,
H), 7.39–7.26 (m, 6 H), 7.10 (dt, J = 1.4, 10.3 Hz, 1 H), 7.02 (dd,
J = 1.3, 11.0 Hz, 1 H), 6.89 (s, 1 H), 6.15 (d, J = 4.4 Hz, 1 H), 5.31
(AB q, ΔδAB = 0.09 ppm, JAB = 16.2 Hz, 2 H), 4.49–4.35 (m, 2 H)
ppm. 13C NMR (100 MHz, CDCl3): δ = 162.1, 149.8, 137.9, 135.2,
135.0, 129.5, 128.71, 128.68, 128.4, 127.3, 126.0, 120.7, 119.2, 67.3,
66.6, 55.9 ppm. HRMS (ESI): calcd. for C18H16NO5S [M + H]+
358.0744; found 358.0740.
56.2 ppm. HRMS (ESI): calcd. for C19H18NO6S [M + H]+
388.0849; found 388.0851.
Benzyl 7-Methoxy-3,10b-dihydrobenzo[e]pyrrolo[1,2-c][1,2,3]oxathi-
azine-1-carboxylate 5,5-Dioxide (3h): Rf = 0.30 (petroleum ether/
ethyl acetate, 5:1). 1H NMR (400 MHz, CDCl3): δ = 7.39–7.36 (m,
5 H), 7.13 (d, J = 7.9 Hz, 1 H), 7.02 (t, J = 8.1 Hz, 1 H), 6.88–6.86
(m, 2 H), 6.14 (d, J = 4.1 Hz, 1 H), 5.30 (AB q, ΔδAB = 0.08 ppm,
JAB = 12.2 Hz, 2 H), 4.49–4.36 (m, 2 H), 3.87 (s, 3 H) ppm. 13C
NMR (100 MHz, CDCl3): δ = 162.1, 149.0, 139.5, 137.9, 135.2,
135.0, 128.70, 128.65, 128.4, 125.6, 121.6, 118.2, 111.9, 67.2, 66.7,
56.2, 56.0 ppm. HRMS (EI): calcd. for C19H17O6NS [M]+
387.0777; found 387.0774.
Benzyl
9-Fluoro-3,10b-dihydrobenzo[e]pyrrolo[1,2-c][1,2,3]oxathi-
azine-1-carboxylate 5,5-Dioxide (3b): Rf = 0.32 (petroleum ether/
ethyl acetate, 5:1). 1H NMR (400 MHz, CDCl3): δ = 7.44–7.40 (m,
6 H), 7.01–6.99 (m, 2 H), 6.92 (s, 1 H), 6.09 (s, 1 H), 5.32 (AB q,
ΔδAB = 0.07 ppm, JAB = 12.2 Hz, 2 H), 4.42 (m, 2 H) ppm. 13C
1
NMR (100 MHz, CDCl3): δ = 162.0, 159.5 (d, JC-F = 244.5 Hz),
Benzyl 9-(Diethylamino)-3,10b-dihydrobenzo[e]pyrrolo[1,2-c][1,2,3]-
oxathiazine-1-carboxylate 5,5-Dioxide (3i): Rf = 0.50 (petroleum
ether/ethyl acetate, 5:1). 1H NMR (400 MHz, CDCl3): δ = 7.40–
7.33 (m, 6 H), 6.82 (s, 1 H), 6.39 (dd, J = 2.6, 8.9 Hz, 1 H), 6.22
(d, J = 2.6 Hz, 1 H), 6.03 (d, J = 3.9 Hz, 1 H), 5.30 (AB q, ΔδAB
= 0.08 ppm, JAB = 12.2 Hz, 2 H), 4.41–4.33 (m, 2 H), 3.30 (q, J =
7.1 Hz, 4 H), 1.14 (t, J = 7.1 Hz, 6 H) ppm. 13C NMR (100 MHz,
CDCl3): δ = 162.3, 150.9, 148.4, 137.0, 135.9, 135.1, 128.7, 128.5,
128.3, 127.8, 109.3, 106.0, 100.6, 67.0, 66.3, 55.9, 44.3, 12.4 ppm.
HRMS (ESI): calcd. for C22H24N2O5NaS [M + Na]+ 451.1304;
found 451.1307.
4
145.7 (d, JC-F = 2.8 Hz), 138.4, 134.8, 134.7, 128.8, 128.5, 122.2
3
3
2
(d, JC-F = 7.5 Hz), 120.8 (d, JC-F = 8.3 Hz), 116.5 (d, JC-F
=
=
2
4
23.8 Hz), 114.2 (d, JC-F = 25.8 Hz), 109.9, 67.5, 66.5 (d, JC-F
2.6 Hz), 56.0 ppm. HRMS (ESI): calcd. for C18H14FNNaO5S [M
+ Na]+ 398.0469; found 398.0472.
Benzyl 9-Chloro-3,10b-dihydrobenzo[e]pyrrolo[1,2-c][1,2,3]oxathi-
azine-1-carboxylate 5,5-Dioxide (3c): Rf = 0.26 (petroleum ether/
1
ethyl acetate, 5:1). H NMR (400 MHz, CDCl3): δ = 7.68 (s, 1 H),
7.40–7.38 (m, 5 H), 7.26–7.24 (m, 1 H), 6.98–6.92 (m, 2 H), 6.09
(s, 1 H), 5.32 (AB q, ΔδAB = 0.05 ppm, JAB = 9.9 Hz, 2 H), 4.46–
4.37 (m, 2 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 162.2, 148.6,
138.6, 135.0, 134.9, 131.4, 129.8, 129.01, 129.00, 128.8, 127.6,
122.4, 120.8, 67.8, 66.6, 56.2 ppm. HRMS (ESI): calcd. for
C18H18ClN2O5S [M + NH4]+ 409.0620; found 409.0615.
Benzyl 7,9-Dibromo-3,10b-dihydrobenzo[e]pyrrolo[1,2-c][1,2,3]oxa-
thiazine-1-carboxylate 5,5-Dioxide (3j): Rf = 0.29 (petroleum ether/
1
ethyl acetate, 5:1). H NMR (400 MHz, CDCl3): δ = 7.83 (s, 1 H),
7.68 (s, 1 H), 7.40 (s, 5 H), 6.94 (s, 1 H), 6.10 (s, 1 H), 5.35–5.29
(m, 2 H), 4.50–4.39 (m, 2 H) ppm. 13C NMR (100 MHz, CDCl3):
δ = 161.8, 146.0, 138.6, 135.7, 134.7, 134.4, 129.4, 128.8, 128.6,
124.0, 118.6, 113.9, 67.6, 66.5, 56.2 ppm. HRMS (EI): calcd. for
C18H13O5NBr2S [M]+ 512.8881; found 512.8886.
Benzyl
9-Bromo-3,10b-dihydrobenzo[e]pyrrolo[1,2-c][1,2,3]oxathi-
azine-1-carboxylate 5,5-Dioxide (3d): Rf = 0.24 (petroleum ether/
1
ethyl acetate, 5:1). H NMR (400 MHz, CDCl3): δ = 7.83 (s, 1 H),
7.41 (s, 6 H), 6.93–6.91 (m, 2 H), 6.10 (s, 1 H), 5.36–5.29 (m, 2 H),
4.42 (s, 2 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 161.9, 148.9,
138.4, 134.8, 134.7, 132.6, 130.3, 128.82, 128.79, 128.60, 122.6,
120.9, 118.7, 67.6, 66.3, 56.0 ppm. HRMS (ESI): calcd. for
C18H18BrN2O5S [M + NH4]+ 453.0114; found 453.0108.
Benzyl 7-Bromo-9-chloro-3,10b-dihydrobenzo[e]pyrrolo[1,2-c][1,2,3]-
oxathiazine-1- carboxylate 5,5-Dioxide (3k): Rf = 0.32 (petroleum
1
ether/ethyl acetate, 5:1). H NMR (400 MHz, CDCl3): δ = 7.69 (s,
1 H), 7.54 (s, 1 H), 7.40 (s, 5 H), 6.94 (s, 1 H), 6.09 (s, 1 H), 5.32
(AB q, ΔδAB = 0.05 ppm, JAB = 12.1 Hz, 2 H), 4.39–4.50 (m, 2 H)
ppm. 13C NMR (100 MHz, CDCl3): δ = 161.8, 145.5, 138.6, 134.7,
134.4, 132.9, 131.3, 128.8, 128.6, 126.5, 123.6, 113.6, 67.6, 66.6,
56.2 ppm. HRMS (EI): calcd. for C18H13O5NBrClS [M]+ 468.9386;
found 468.9390.
Benzyl 9-Methyl-3,10b-dihydrobenzo[e]pyrrolo[1,2-c][1,2,3]oxathi-
azine-1-carboxylate 5,5-Dioxide (3e): Rf = 0.32 (petroleum ether/
ethyl acetate, 5:1). 1H NMR (400 MHz, CDCl3): δ = 7.41–7.35 (m,
6 H), 7.07 (d, J = 8.3 Hz, 1 H), 6.92–6.89 (m, 2 H), 6.10 (s, 1 H),
5.33 (AB q, ΔδAB = 0.08 ppm, JAB = 12.2 Hz, 2 H), 4.45–4.36 (m,
2 H), 2.19 (s, 3 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 162.2,
147.7, 137.9, 135.8, 135.3, 135.1, 130.1, 128.74, 128.71, 128.5,
127.4, 120.2, 118.9, 67.2, 66.6, 55.9, 20.8 ppm. HRMS (ESI): calcd.
for C19H17NNaO5S [M + Na]+ 394.0720; found 394.0713.
Benzyl 7,9-Di-tert-butyl-3,10b-dihydrobenzo[e]pyrrolo[1,2-c][1,2,3]-
oxathiazine-1-carboxylate 5,5-Dioxide (3l): Rf = 0.30 (petroleum
ether/ethyl acetate, 10:1), identical to imine 1l. 1H NMR (400 MHz,
CDCl3): δ = 7.56 (d, J = 1.8 Hz, 1 H), 7.38–7.33 (m, 5 H), 7.31 (d,
J = 2.2 Hz, 1 H), 6.87 (s, 1 H), 6.15 (d, J = 4.2 Hz, 1 H), 5.29 (AB
q, ΔδAB = 0.14 ppm, JAB = 12.2 Hz, 2 H), 4.51–4.37 (m, 2 H), 1.41
(s, 9 H), 1.22 (s, 9 H) ppm. 13C NMR (100 MHz, CDCl3): δ =
162.3, 148.0, 146.7, 139.4, 137.7, 135.6, 135.1, 128.7, 128.6, 128.5,
124.1, 122.1, 120.3, 67.2, 67.1, 56.3, 35.1, 34.7, 31.2, 30.0 ppm.
HRMS (ESI): calcd. for C26H31NO5NaS [M + Na]+ 492.1821;
found 492.1828.
Benzyl 9-Methoxyl-3,10b-dihydrobenzo[e]pyrrolo[1,2-c][1,2,3]oxathi-
azine-1-carboxylate 5,5-Dioxide (3f): Rf = 0.39 (petroleum ether/
1
ethyl acetate, 5:1). H NMR (400 MHz, CDCl3): δ = 7.39 (s, 5 H),
7.19 (s, 1 H), 6.96–6.91 (m, 2 H), 6.81 (d, J = 9.0 Hz, 1 H), 6.10
(s, 1 H), 5.30 (s, 2 H), 4.46–4.36 (m, 2 H), 3.62 (s, 3 H) ppm. 13C
NMR (100 MHz, CDCl3): δ = 162.3, 157.1, 143.3, 138.2, 135.0,
128.70, 128.65, 128.4, 121.3, 120.1, 115.7, 111.2, 67.3, 66.7, 56.0,
55.5 ppm. HRMS (EI): calcd. for C19H17O6NS [M]+ 387.0777;
found 387.0777.
Cycloaddition Reaction with Cyclic Trifluoromethyl Ketimine 4:
Scheme 3. To allenoate 2a (0.225 mmol, 39.2 mg) in anhydrous tol-
uene (0.75 mL) was added ketimine 4 (0.15 mmol, 37.7 mg) and
Ph3P (10 mol-%, 0.015 mmol, 4.0 mg). The mixture was stirred at
room temperature for 1 h, but no reaction occurred as shown by
Benzyl 8-Methoxy-3,10b-dihydrobenzo[e]pyrrolo[1,2-c][1,2,3]oxathi-
azine-1-carboxylate 5,5-Dioxide (3g): Rf = 0.44 (petroleum ether/
1
ethyl acetate, 3:1). H NMR (400 MHz, CDCl3): δ = 7.48 (d, J = TLC. Then the mixture was heated to 50 °C overnight (12 h), and
8.7 Hz, 1 H), 7.39 (s, 5 H), 6.86 (s, 1 H), 6.65 (d, J = 8.8 Hz, 1 H), analysis by using TLC indicated full conversion. After cooling to
6.54 (s, 1 H), 6.07 (s, 1 H), 5.30 (AB q, ΔδAB = 0.09 ppm, JAB
=
room temperature, the toluene solution was directly charged on
12.1 Hz, 2 H), 4.46–4.35 (m, 2 H), 3.77 (s, 3 H) ppm. 13C NMR silica gel and purified by column chromatography (petroleum ether/
(100 MHz, CDCl3): δ = 162.8, 160.9, 151.3, 138.2, 136.1, 135.7, ethyl acetate) to afford the desired product (48.6 mg, 76% yield).
3768
www.eurjoc.org
© 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2013, 3764–3770